Generali Investments Towarzystwo Funduszy Inwestycyjnych Exact Sciences Corp Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $172 Billion
- Q4 2024
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Exact Sciences Corp stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 24,000 shares of EXAS stock, worth $1.31 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
24,000
Previous 18,000
33.33%
Holding current value
$1.31 Million
Previous $1.23 Billion
9.98%
% of portfolio
0.78%
Previous 0.78%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
659Shares Held
161MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$973 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$867 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$785 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$661 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$366 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.69B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...